RGEN vs SOLV
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
RGEN · Repligen$173.49 ▲ 2.97%
SOLV · Solventum$90.38 ▲ 3.67%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- RGEN +19.1%
- SOLV +25.9%
Head to head
| Metric | RGEN | SOLV |
|---|---|---|
| Price | $173.49 | $90.38 |
| Change today | ▲ 2.97% | ▲ 3.67% |
| Market cap | $11.09B | $15.34B |
| Return, 3 months | +6.3% | +6.1% |
| Return, year to date | +5.9% | +14.1% |
| Return, 1 year | +21.5% | +26.4% |
| P/E (TTM) | – | 101.6 |
| P/B | 5.3 | 3.2 |
| P/E percentile vs own 5y | 11th | 100th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +10.9% | +2.2% |
| Net profit growth (YoY) | -357.7% | +3.3% |
| Gross margin | 53.5% | 54.7% |
| Operating margin | 7.6% | 6.3% |
| Net margin | -1.5% | 17.3% |
| Return on equity | -0.6% | 34.0% |
| Analyst target vs. price | +21.2% | +12.4% |
| Analyst buy share | 88% | 63% |
| RSI (14) | 47 | 59 |
| 30-day volatility | 58.7% | 32.1% |
| Max drawdown, 1 year | -40.3% | -27.5% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- SOLV is the largest of the group by market value.
- SOLV has returned the most over the past year.
- RGEN is growing revenue fastest.
- SOLV keeps the most profit per dollar of sales.
- SOLV has been the calmest stock over the last 30 days.